Modular Medical (Nasdaq:MODD) announced today that it validated its insulin pump cartridge line for human-use production in ...

Swiss entrepreneur Willy Michel, who founded Ypsomed, controls TecMed. His son, Simon Michel, is CEO of Ypsomed. Included in ...

Sava Technologies announced today that it raised $19 million in a Series A financing round to support its wearable biosensor ...

Trividia Health announced today that it launched its new TRUEplus five-bevel insulin pen needle line in the UK.

Dexcom (Nadsaq:DXCM) today reported second-quarter financial results that came in ahead of the consensus forecast.

What has changed in the last year as diabetes technology developers continue to innovate and advance their offerings?

Sayer originally joined Dexcom’s board in November 2007, then became president in 2011. He held the role of COO, like Leach, until his promotion to CEO in 2015.

“The CMS determination is a positive development for patients with in-stent restenosis and supports clinical findings that the Agent DCB is statistically superior to conventional balloon angioplasty ...